Keywords: Sihuan Pharma. Dupromise, China, Cardio-cerebral vascular medicines

Sihuan Pharma to buy fellow Chinese drugmaker Dupromise for $360.7 million

Article | 29 November 2010

According to a filing with the Hong Kong Stock Exchange, Sihuan Pharmaceutical, the second-largest cardio-cerebral vascular drugmaker in China, plans ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Dupromise

Sihuan Pharmaceutical

Go to company listing